Position in ABBV
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$2,135,165
+$327,171 QoQ
Shares Held
8,485
+2.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
3.11%
of 13F equity value
Holder Rank
#1,917
of 4,153 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Significant Wealth Partners LLC holds $2,651,011 across 2 Drug Manufacturers - General names. ABBV ranks #1 (80.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
8,485 | $2,135,165 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
4,083 | $515,846 |
All Filings in ABBV
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,135,165 | 8,485 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $1,807,994 | 8,313 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $756,987 | 3,313 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $1,589,290 | 6,864 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $1,294,885 | 6,976 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $1,465,382 | 6,994 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $1,251,896 | 7,045 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $1,551,797 | 7,858 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,327,907 | 7,742 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $1,729,039 | 9,495 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $1,162,275 | 7,500 | Shares | Sole | 2024-02-01 | |
| No filing history on record for this holder in this stock. | ||||||